Product NDC: | 50268-467 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | Levetiracetam |
Active Ingredient(s): | 250 mg/1 & nbsp; Levetiracetam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50268-467 |
Labeler Name: | AvPAK |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077319 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090320 |
Package NDC: | 50268-467-11 |
Package Description: | 100 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (50268-467-11) |
NDC Code | 50268-467-11 |
Proprietary Name | Levetiracetam |
Package Description | 100 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (50268-467-11) |
Product NDC | 50268-467 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levetiracetam |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20090320 |
Marketing Category Name | ANDA |
Labeler Name | AvPAK |
Substance Name | LEVETIRACETAM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |